Eye Diseases
Showing NaN - NaN of 8
Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,
Recruiting
- Thyroid Eye Disease
- +11 more
- Linsitinib
- Placebo
-
Beverly Hills, California
- +22 more
Jan 30, 2023
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)
Recruiting
- Retinitis Pigmentosa
- +7 more
- Ultevursen
- Sham-procedure
-
San Diego, California
- +14 more
Jul 29, 2022
Macular Degeneration, Retinal Degeneration, Retinal Diseases Trial in Boston (Pistachio Group)
Recruiting
- Macular Degeneration
- +3 more
- Pistachio Group
-
Boston, MassachusettsClinical and Translational Research Center (CTRC) - Tufts
Jun 9, 2022
Natural History Study of CEP290-Related Retinal Degeneration
Completed
- Blindness
- +7 more
-
Miami, Florida
- +6 more
May 18, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose
Completed
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure (dose cohort 1&2 only)
-
Boston, Massachusetts
- +6 more
Apr 19, 2022
Rate of Progression in EYS Related Retinal Degeneration
Active, not recruiting
- Retinitis Pigmentosa
- Eye Diseases
-
San Francisco, California
- +19 more
Feb 3, 2022
Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease Trial in United Kingdom, United States (GT005)
Recruiting
- Dry Age-related Macular Degeneration
- +6 more
- GT005
-
Saint Petersburg, Florida
- +12 more
Dec 21, 2021
Macular Degeneration, Age-Related Maculopathies, Age-Related Maculopathy Trial in United States (AAV2-sFLT01)
Completed
- Macular Degeneration
- +9 more
- AAV2-sFLT01
-
Baltimore, Maryland
- +3 more
Aug 21, 2018